
News|Articles|November 20, 2023
Data is Becoming a Differentiator for Hubs that Support Specialty Drugs
Author(s)CareMetx
In a recent study, CareMetx engaged with senior leadership at leading biopharmaceutical manufacturers, aiming to evaluate the optimal ways in which Hub data can enhance manufacturer support. These findings can serve as a valuable guide for manufacturers seeking insights on optimizing their utilization of Hub data.
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
FAQ: Inside the Latest MFN Deals Signed by Nine Drugmakers
2
How Rising Cargo Theft Puts New Pressure on the Pharma Supply Chain
3
Gregg Gorniak on Turning DSCSA Compliance Investment Into Shared Value
4
Why the Biggest NDC-12 Risk Sits in the Handoffs
5